UPDATE 1-Roche's Tecentriq fails trial in advanced bladder cancer

ZURICH, May 10 (Reuters) - Roche's Tecentriq drug has failed a late-stage trial in people with previously treated advanced bladder cancer, the Swiss drugmaker said on Wednesday, a setback in its plans to expand use of the immunotherapy.

by reutersCOMPANYNEWS via Endless Supplies .Biz - News